Krishna Institute of Medical Sciences and Dakshayani Healthcare Services Forge Partnership to Advance Oncology Care
Krishna Institute of Medical Sciences Limited (KIMS) has entered into a non-commercial brand association agreement with Dakshayani Healthcare Services Private Limited (Renova) to bolster its capabilities and enhance standards in oncology services.The collaboration formalizes a mutual partnership between the two organizations. Renova, a specialized oncology organization, brings proprietary clinical protocols, expertise in cancer research, and extensive experience managing cancer centers across India.
Under the terms of the association, both KIMS and RENOVA will collaborate on a noncommercial basis. The primary focus of the collaboration is RENOVA sharing its clinical expertise, knowledge, and best practices in Oncology care with KIMS. The arrangement is specifically intended to strengthen healthcare delivery standards, particularly within oncology services, ultimately aiming to enhance patient care outcomes.
The partnership provides a framework for mutual growth and development. Renova anticipates enhancing its brand positioning through the association with Krishna Institute of Medical Sciences. Concurrently, KIMS will benefit from fostering the collaborative development of clinical protocols and treatment methodologies with Renova. This creates a mutually reinforcing partnership designed to advance the standards of oncology care.
KIMS Stock Price Movement
Krishna Institute of Medical Sciences Limited shares today slipped by 3.70% to settle at ₹654.95. The stock saw significant activity, recording a total volume of 1.86 million shares in trading today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.